Intelligent Menopause Relief System

Publication ID: 24-11857458_0003_PTD

Published: October 28, 2025

Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Intelligent Menopause Relief System,” Published Technical Disclosure No. 24-11857458_0003_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857458_0003_PTD

This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,458.

Summary of the Inventive Concept

An integrated system combining a freezable insert device with AI, IoT, blockchain, and novel materials to provide personalized, adaptive, and secure relief from menopausal symptoms.

Background and Problem Solved

The original freezable insert device addressed hot flashes in menopausal women, but its limitations included lack of real-time monitoring, limited adjustability, and potential counterfeiting risks. The new inventive concept resolves these issues by incorporating advanced technologies to create a more effective, user-centric, and trustworthy solution.

Detailed Description of the Inventive Concept

The Intelligent Menopause Relief System consists of a freezable insert device with a phase-change material core, a wearable IoT device monitoring body temperature, an AI-powered analytics module adjusting the device's temperature and vibration patterns, a blockchain-based platform ensuring authenticity and regulatory compliance, and a mobile app for remote control and personalized recommendations. The system provides real-time feedback, adaptive relief, and enhanced safety and comfort.

Novelty and Inventive Step

The new claims introduce the innovative combination of AI, IoT, blockchain, and novel materials with the original freezable insert device, enabling a synergistic system that offers unprecedented levels of personalization, adaptability, and security in menopause relief.

Alternative Embodiments and Variations

Alternative embodiments may include varying the wearable IoT device's form factor, using different AI algorithms, or incorporating additional sensors to monitor other physiological parameters. Variations could also involve integrating the system with existing healthcare infrastructure or expanding its application to other health conditions.

Potential Commercial Applications and Market

The Intelligent Menopause Relief System has significant commercial potential in the women's health and wellness market, with potential applications in telemedicine, healthcare services, and pharmaceutical industries. The system's adaptability and security features also make it an attractive solution for healthcare providers and regulatory bodies.

CPC Classifications

Section	Class	Group
A	A61	A61F7/12
A	A61	A61L31/042
A	A61	A61F13/34
A	A61	A61F2007/005
A	A61	A61F2007/0219
A	A61	A61F2007/108
A	A61	A61H23/02
A	A61	A61H2205/087

Section 103 Obviousness Analysis (PHOSITA)

▼

Field of Art

Medical device design, specifically thermal therapeutic devices for women's health, focusing on menopause symptom management with expertise in materials science, thermal engineering, and biomedical device integration

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or medical device designer with advanced degree, experience in thermal therapeutic technologies, understanding of women's health applications, familiarity with IoT and adaptive medical technologies

Obviousness Rationale

A PHOSITA would recognize that integrating digital monitoring, AI adaptation, and advanced materials with the base freezable insert device represents predictable technological evolution. The core thermal relief concept remains consistent while adding contemporary technological enhancements. These variations represent standard engineering problem-solving approaches to improving medical device functionality and user experience.

Obvious Combinations & Variations

Source Patent Element

Freezable core assembly for vaginal insertion to reduce menopausal symptoms

PTD Variation

Adding IoT temperature monitoring and AI-driven adaptive temperature control

Obviousness Reasoning

Integrating sensor technologies with medical devices is a known technique, and applying real-time monitoring to improve therapeutic effectiveness represents a predictable technological enhancement

Source Patent Element

Non-toxic gel core with temperature retention capabilities

PTD Variation

Implementing phase-change materials with more sophisticated thermal energy storage and controlled release

Obviousness Reasoning

Material science advances in thermal regulation are foreseeable improvements, and selecting advanced phase-change materials represents an obvious design optimization

Source Patent Element

String-based removal mechanism for the freezable insert

PTD Variation

Blockchain-based authentication and regulatory compliance tracking system

Obviousness Reasoning

Implementing digital authentication for medical devices is a standard approach to ensuring product safety and traceability, representing an obvious technological progression

Source Patent Element

Basic vaginal insert device for symptom management

PTD Variation

Mobile application for remote device control and personalized health recommendations

Obviousness Reasoning

Extending medical devices with smartphone interfaces is a predictable technological evolution, solving user interaction and personalization challenges

35 U.S.C. § 103 Summary: Based on US Patent 11857458's foundational teachings of a freezable vaginal insert device, the present publication demonstrates that the claimed technological variations represent obvious extensions readily apparent to a Person Having Ordinary Skill In The Art, thereby establishing anticipatory prior art that would render subsequent substantially similar claims obvious and non-patentable.

Original Patent Information

Patent Number	US 11,857,458
Title	Freezable insert device